Management of adverse effects associated with the use of interleukin-2 in patients with HIV infection.
Therapy with interleukin-2 challenges both the patient and the clinic staff. Pre-education and side effect management are crucial to the successful administration of each cycle of interleukin-2.
Charland
Mary Beth
MB
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000855:Anorexia / Q000139:chemically induced; D018791:CD4 Lymphocyte Count; D002493:Central Nervous System Diseases / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000209:etiology; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D005334:Fever / Q000139:chemically induced; D015658:HIV Infections / Q000188:drug therapy* / Q000451:nursing / Q000821:virology; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D009325:Nausea / Q000139:chemically induced; D024802:Nurse's Role; D010347:Patient Care Planning; D017211:Treatment Failure; D019562:Viral Load; D014779:Virus Replication; D014839:Vomiting / Q000139:chemically induced
D000276:Adjuvants, Immunologic; D007376:Interleukin-2